Overview

Micafungin Prevention Study for Invasive Fungal Disease in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation

Status:
Unknown status

Trial end date:
2014-12-01

Target enrollment:

Participant gender:

Summary

This study is to evaluate safety and prophylaxis effect of micafungin after hematopoietic stem cell transplantation. Micafungin is administered until confirmation of neutrophil engraftment or treatment failure.

Phase:

Phase 2

Details

Lead Sponsor:

Seoul National University Hospital

Treatments:

Echinocandins
Micafungin